🧪
Active substance
autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel)
✅ No active alerts
1 EU-authorised brand(s)
✅
All clear right now
No active EU-wide shortages or safety letters for this substance. National-level issues may still exist.